MedTrace Logo

Therapeutic Drug Monitoring of Teicoplanin in Children

NCT03933748 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-04-14

No results posted yet for this study

Summary

In this study, the therapeutic drug monitoring of teicoplanin is carried out among children to obtain the drug concentration, clinical efficacy and safety data of children patients in different gender and age groups. Then we analyze the relationship between blood drug concentration and efficacy and safety, and provide recommendations for the treatment window of teicoplanin in Chinese children.

Conditions

Interventions

DRUG

Teicoplanin-PMMA

Therapeutic drug monitoring of teicoplanin

Sponsors & Collaborators

  • Qianfoshan Hospital

    collaborator OTHER

  • Shandong Provincial Hospital

    collaborator OTHER_GOV

  • Affiliated Hospital of Qinghai University

    collaborator OTHER

  • Jinan children's hospital

    collaborator UNKNOWN

  • Yantai Yuhuangding Hospital

    collaborator OTHER

  • Jinan Central Hospital

    collaborator OTHER

  • Liaocheng People's Hospital

    collaborator OTHER

  • Shandong Tumor Hospital

    collaborator OTHER

  • Weifang People's Hospital

    collaborator OTHER

  • Linyi People's Hospital

    collaborator OTHER

  • Jining Medical University

    collaborator OTHER

  • Weihai maternal and child health care hospital

    collaborator UNKNOWN

  • The Second Hospital of Shandong University

    collaborator OTHER

  • Shandong University

    lead OTHER

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2025-11-30
Completion
2025-12-31
FDA Drug
Yes

Countries

  • China

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03933748 on ClinicalTrials.gov